drugset / Trial / NCT00299455

Amoxicillin Clavulanate in Treatment of Acute Otitis Media

NCT00299455 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a prospective, randomized, double-blind, placebo controlled one-center study carried out in primary care setting of the health center of City of Turku, Finland. The study patients will be allocated to one of the two parallel treatment groups (amoxicillin-clavulanate or placebo). The hypothesis is that the symptoms and signs of acute otitis media are resolved more effectively with antimicrobial treatment than with placebo. Furthermore, this study aims at finding out prognostic factors that could help to direct antimicrobial treatment for correct subgroups of young patients.

Timeline

Start
2006-03
Primary completion
2008-12
Completion
2009-03

Outcome

Met primary endpoint

paper Treatment failure occurred in 18.6% of the children who received amoxicillin-clavulanate, as compared with 44.9% of the children who received placebo (P<0.001). PMID 21226577 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin-clavulanate Other / unclassified 40 mg/kg —

Indications